Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Viral Vector Vaccine Development and Application during the COVID-19 Pandemic
Shaofeng Deng, Hui Liang, Chen Pin, et al.
Microorganisms (2022) Vol. 10, Iss. 7, pp. 1450-1450
Open Access | Times Cited: 68

Showing 1-25 of 68 citing articles:

Two centuries of vaccination: historical and conceptual approach and future perspectives
David A. Montero, Roberto Vidal, Juliana Velasco, et al.
Frontiers in Public Health (2024) Vol. 11
Open Access | Times Cited: 29
Construction and application of adenoviral vectors
Hongbo Zhang, Hongdan Wang, Youcai An, et al.
Molecular Therapy — Nucleic Acids (2023) Vol. 34, pp. 102027-102027
Open Access | Times Cited: 22
Vaccines against Emerging and Neglected Infectious Diseases: An Overview
Larissa Vuitika, Wasim A. Prates-Syed, Jaqueline Dinis Queiros Silva, et al.
Vaccines (2022) Vol. 10, Iss. 9, pp. 1385-1385
Open Access | Times Cited: 30
COVID-19 Vaccines over Three Years after the Outbreak of the COVID-19 Epidemic
Aleksandra Anna Zasada, Aniela Darlińska, Aldona Wiatrzyk, et al.
Viruses (2023) Vol. 15, Iss. 9, pp. 1786-1786
Open Access | Times Cited: 20
From private incentives to public health need: rethinking research and development for pandemic preparedness
Els Torreele, Daniel Wolfe, Michel D. Kazatchkine, et al.
The Lancet Global Health (2023) Vol. 11, Iss. 10, pp. e1658-e1666
Open Access | Times Cited: 19
HBV Vaccines: Advances and Development
Faisal Mahmood, Ruixian Xu, Maher Un Nisa Awan, et al.
Vaccines (2023) Vol. 11, Iss. 12, pp. 1862-1862
Open Access | Times Cited: 17
Precision-engineering of subunit vaccine particles for prevention of infectious diseases
Shuxiong Chen, Saranya Pounraj, Nivethika Sivakumaran, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 15
COVID-19 Variants and Vaccine Development
Ziyao Zhao, Sahra Bashiri, Zyta M. Ziora, et al.
Viruses (2024) Vol. 16, Iss. 5, pp. 757-757
Open Access | Times Cited: 5
COVID-19: The vaccine development strategies
Zhipeng Yan, Ming Yang, Ching‐Lung Lai
Elsevier eBooks (2025), pp. 645-667
Closed Access
Cytokine response against vaccinia virus
S. Syed Shafi, Hafizurrahman Khan, Preeti Bajpai
Elsevier eBooks (2025), pp. 53-78
Closed Access
Comparative efficacy of leading COVID-19 vaccines: A network meta-analysis
Sanjay Rai, Shashank Tripathi
The Indian Journal of Medical Research (2025) Vol. 161, pp. 9-20
Open Access
Nanoparticles and Antiviral Vaccines
Sen L, Meilin Hu, Xiaoqing Liu, et al.
Vaccines (2023) Vol. 12, Iss. 1, pp. 30-30
Open Access | Times Cited: 13
Exigency of Plant-Based Vaccine against COVID-19 Emergence as Pandemic Preparedness
Anirudha Chattopadhyay, A. Abdul Kader Jailani, Bikash Mandal
Vaccines (2023) Vol. 11, Iss. 8, pp. 1347-1347
Open Access | Times Cited: 12
Development of variant‐proof severe acute respiratory syndrome coronavirus 2, pan‐sarbecovirus, and pan‐β‐coronavirus vaccines
Jie Zhou, Zezhong Liu, Guangxu Zhang, et al.
Journal of Medical Virology (2022) Vol. 95, Iss. 1
Open Access | Times Cited: 21
Recent development of oral vaccines (Review)
Ying Liu, Dominic Man‐Kit Lam, Mei Luan, et al.
Experimental and Therapeutic Medicine (2024) Vol. 27, Iss. 5
Open Access | Times Cited: 3
Modeling and analysis of novel COVID-19 outbreak under fractal-fractional derivative in Caputo sense with power-law: a case study of Pakistan
Khadija Tul Kubra, Rooh Ali
Modeling Earth Systems and Environment (2023) Vol. 9, Iss. 4, pp. 3865-3882
Open Access | Times Cited: 9
Advances in nanoparticle-based mRNA delivery for liver cancer and liver-associated infectious diseases
Seokhwan Chung, Chan Mi Lee, Miqin Zhang
Nanoscale Horizons (2022) Vol. 8, Iss. 1, pp. 10-28
Open Access | Times Cited: 15
The Novavax Heterologous Coronavirus Disease 2019 Booster Demonstrates Lower Reactogenicity Than Messenger RNA: A Targeted Review
Anthony M. Marchese, Matthew D. Rousculp, John C. Macbeth, et al.
The Journal of Infectious Diseases (2023) Vol. 230, Iss. 2, pp. e496-e502
Open Access | Times Cited: 8
Pharmacovigilance in Vaccines: Importance, Main Aspects, Perspectives, and Challenges—A Narrative Review
Katharine Valéria Saraiva Hodel, Bianca Sampaio Dotto Fiuza, Rodrigo Souza Conceição, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 6, pp. 807-807
Open Access | Times Cited: 2
Novel Administration Routes, Delivery Vectors, and Application of Vaccines Based on Biotechnologies: A Review
Chung-I Rai, Tsu-Hsiang Kuo, Yuan‐Chuan Chen
Vaccines (2024) Vol. 12, Iss. 9, pp. 1002-1002
Open Access | Times Cited: 2
Parainfluenza virus 5 is a next‐generation vaccine vector for human infectious pathogens
Ting Wang, Lilan Zheng, Qiujian Zhao, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 3
Closed Access | Times Cited: 5
COVID-19 Variants and Vaccine Development
Ziyao Zhao, Sahra Bashiri, Zyta M. Ziora, et al.
(2024)
Open Access | Times Cited: 1
Sequence confirmation of synthetic DNA exceeding 100 nucleotides using restriction enzyme mediated digestion combined with high-resolution tandem mass spectrometry
Christian Sattler, Burak Ceylan, Luísa Hoffmann, et al.
Journal of Pharmaceutical and Biomedical Analysis (2024) Vol. 245, pp. 116180-116180
Closed Access | Times Cited: 1
COVID-19 Vaccines Breakthrough Infections and Adverse Effects Reported by the Birzeit University Community in Palestine
Abdallah Damin Abukhalil, Raya Riyad Abushehadeh, Sireen Sultan Shatat, et al.
International Journal of General Medicine (2024) Vol. Volume 17, pp. 3349-3360
Open Access | Times Cited: 1
Global Challenges After a Global Challenge: Lessons Learned from the COVID-19 Pandemic
Niloufar Yazdanpanah, Constantine Sedikides, Hans D. Ochs, et al.
Advances in experimental medicine and biology (2024), pp. 1-31
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top